Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Has The Inherited Retinal Disease Market Size Shifted, And What Is the Outlook Through 2034?
The market size for inherited retinal diseases has recently been experiencing significant growth. In fact, it is projected to expand from the value of $11.56 billion in 2024, escalating to $12.54 billion by 2025, with a compound annual growth rate (CAGR) of 8.5%. Factors contributing to the growth during the historical period include the utilization of gene therapy, regulatory incentives put into place, an increase in patient registries, a surge in clinical trials, and the implementation of solutions focused on patient needs.
Predictions indicate that the market size for inherited retinal disease is on track for substantial growth in the next few years, escalating to $17.26 billion by 2029 with a CAGR of 8.3%. The surge in this period is likely due to the prevalent use of CRISPR, initiation of bespoke treatments, concentration on regenerative medicine, an increase in patient advocacy, and a commitment towards enhancing patients’ quality of life. The forecasted period also exhibits a host of significant trends, including progress in optogenetics technology, production of artificial retina implants, spread of digital health platforms, the incorporation of artificial intelligence in disease prediction, and the utilization of artificial intelligence in formulating treatments.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20850&type=smp
What Are the Core Market Drivers Propelling Growth in the Inherited Retinal Disease Industry?
The rise in incidences of macular degeneration is anticipated to drive the evolution of the inherited retinal disease market in the years to come. A condition pertaining to the eyes that is related to age, macular degeneration, damages the macula resulting in the loss of central vision and creating obstacles in doing activities like reading or identifying faces. Factors that contribute to the rise of macular degeneration are an aging population, a greater life expectancy, and lifestyle elements such as smoking and inadequate nutrition, which raise the risk. Treatment of inherited retinal diseases aids individuals suffering from macular degeneration by focusing on the genetic reasons that lead to retinal degeneration. They provide therapies that help slow down disease advancement, restore lost vision, or even stop further harm to the retina, ultimately enhancing visual results and the quality of life for people affected by age-related or inherited versions of macular degeneration. For example, the Canadian Ophthalmological Society, a nonprofit organization based in Canada, stated in February 2024 that 2.5 million individuals in Canada aged 55 and over lost their vision owing to age-related macular degeneration (AMD). Hence, the rising incidences of macular degeneration are contributing to the growth of the inherited retinal disease market.
How Is the Inherited Retinal Disease Market Segmented?
The inherited retinal diseasemarket covered in this report is segmented –
1) By Type: Diagnosis; Therapy
2) By Disease Type: Retinitis Pigmentosa; Choroideremia; Stargardt Disease; Cone-rode Dystrophy; Leber Congenital Amaurosis; Other Diseases
3) By Distribution Channel: Retail Sales; Direct Tender
4) By End Users: Hospitals; Speciality Clinics; Ambulatory Surgical Centres; Home Healthcare; Other End Users
Subsegments:
1) By Diagnosis: Genetic Testing (Genetic Screening); Retinal Imaging (Fundus Photography, Optical Coherence Tomography (OCT)); Electrophysiological Testing (Electroretinography); Visual Field Testing; Fundus Autofluorescence Imaging
2) By Therapy: Gene Therapy; Stem Cell Therapy; Retinal Prosthesis (Artificial Retina); Pharmacological Therapy (Gene Editing, Retinal Drugs); Photoreceptor Rescue Therapy
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=20850&type=smp
Which Regions Are Driving the Next Phase of the Inherited Retinal Disease Market Growth?
North America was the largest region in the inherited retinal disease market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the inherited retinal disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Key Market Trends and Innovations Are Shaping the Future of the Inherited Retinal Disease Industry?
Key firms working within the inherited retinal diseases market are concentrating on devising novel therapies such as mutation-agnostic gene therapy. This approach broadens the scope of treatment options and addresses many diverse genetic variations related to these conditions. Mutation-agnostic gene therapy targets wide-ranging genetic mechanisms or pathways instead of particular mutations, which makes it useful for a broad spectrum of genetic disorders. For example, in March 2024, a US-based biotech firm, Nanoscope Therapeutics Inc, reported encouraging results from a clinical trial of its flagship program, MCO-010. The program showed vision enhancement in patients suffering from severe and permanent vision loss due to advanced retinitis pigmentosa. The trial of MCO-010 reached its primary and crucial secondary goals with exceptional statistical significance and no severe adverse outcomes.
View the full report here:
https://www.thebusinessresearchcompany.com/report/inherited-retinal-disease-global-market-report
How Is the Inherited Retinal Disease Market Defined and What Are Its Core Parameters?
Inherited retinal diseases are a group of rare, genetic eye disorders caused by mutations in specific genes. These diseases primarily affect the retina, the thin layer of light-sensitive tissue at the back of the eye. They often present challenges for treatment due to their genetic complexity, but advancements in gene therapy and other innovative technologies offer promising solutions.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20850
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model